Overview
Following subcutaneous administration, the peptide distributes systemically with preferential accumulation in vascular-rich ocular tissues and CNS compartments consistent with its target protein distribution. It crosses limited blood-retinal barrier (BRB) segments under inflammatory conditions due to BRB compromise, which paradoxically may enhance bioavailability at pathological sites. Its molecular chaperone activity is ATP-independent, distinguishing it from Hsp70/Hsp90 family members, allowing action under energy-depleted ischemic conditions.
Proposed mechanism
Crystagen mimics functional domains of alpha-crystallin B (CRYAB), which acts as a molecular chaperone by preventing misfolded protein aggregation and suppressing apoptosis in stressed cells. It modulates the PI3K/Akt and NF-κB signaling pathways, reducing caspase-3 activation and pro-inflammatory cytokine release. Additionally, it may stabilize mitochondrial membrane potential under oxidative stress, protecting photoreceptors and retinal ganglion cells from degeneration.
What the evidence supports
Most data comes from preclinical animal studies. Human clinical trial evidence is limited or absent.
Graded Animal
Evidence drawn from in vivo animal models or in vitro systems. Mechanistically informative; translation to humans is unproven.
Key citations
Representative primary sources, including results that did not favour the compound.
- [1]
Bhanu Bhanu-Kunika et al., Alpha-crystallin B inhibits caspase activation and mitochondrial apoptosis pathways in the ischemic retina
· Investigative Ophthalmology & Visual Science · 2012
- [2]
Kappé G et al., The human genome encodes 10 alpha-crystallin-related small heat shock proteins: HspB1-10
· Cell Stress and Chaperones, Springer · 2003
- [3]
Ousman SS et al., Protective and therapeutic role for αB-crystallin in autoimmune demyelination
· Nature, doi:10.1038/nature05935 · 2007
- [4]
Pangratz-Fuehrer S et al., Alpha-crystallin-derived peptides as neuroprotectants: a review
· Journal of Neurochemistry, Wiley · 2019
Citation records in this build are illustrative placeholders for the design.
Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.